XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance, Beginning at Dec. 31, 2021 $ 5 $ 351,852 $ (514) $ (76,960) $ 274,383
Balance, Beginning (in shares) at Dec. 31, 2021 49,500,308        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options   73     73
Exercise of stock options (shares) 55,998        
Stock-based compensation   1,978     1,978
Other comprehensive loss     (1,418)   (1,418)
Net loss       (14,660) (14,660)
Balance, Ending at Mar. 31, 2022 $ 5 353,903 (1,932) (91,620) 260,356
Balance, Ending (in shares) at Mar. 31, 2022 49,556,306        
Balance, Beginning at Dec. 31, 2021 $ 5 351,852 (514) (76,960) 274,383
Balance, Beginning (in shares) at Dec. 31, 2021 49,500,308        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (30,727)
Balance, Ending at Jun. 30, 2022 $ 5 356,373 (2,336) (107,687) 246,355
Balance, Ending (in shares) at Jun. 30, 2022 49,780,365        
Balance, Beginning at Mar. 31, 2022 $ 5 353,903 (1,932) (91,620) 260,356
Balance, Beginning (in shares) at Mar. 31, 2022 49,556,306        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options   255     255
Exercise of stock options (shares) 197,284        
Purchase of common stock under employee stock purchase plan   178     178
Purchase of common stock under employee stock purchase plan (in shares) 26,775        
Stock-based compensation   2,037     2,037
Other comprehensive loss     (404)   (404)
Net loss       (16,067) (16,067)
Balance, Ending at Jun. 30, 2022 $ 5 356,373 (2,336) (107,687) 246,355
Balance, Ending (in shares) at Jun. 30, 2022 49,780,365        
Balance, Beginning at Dec. 31, 2022 $ 6 492,665 (1,355) (144,600) $ 346,716
Balance, Beginning (in shares) at Dec. 31, 2022 63,257,376       63,257,376
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options   21     $ 21
Exercise of stock options (shares) 17,356        
Stock-based compensation   3,837     3,837
Other comprehensive loss     1,104   1,104
Net loss       (22,838) (22,838)
Balance, Ending at Mar. 31, 2023 $ 6 496,523 (251) (167,438) 328,840
Balance, Ending (in shares) at Mar. 31, 2023 63,274,732        
Balance, Beginning at Dec. 31, 2022 $ 6 492,665 (1,355) (144,600) $ 346,716
Balance, Beginning (in shares) at Dec. 31, 2022 63,257,376       63,257,376
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         $ (44,307)
Balance, Ending at Jun. 30, 2023 $ 6 500,903 (547) (188,907) $ 311,455
Balance, Ending (in shares) at Jun. 30, 2023 63,458,932       63,458,932
Balance, Beginning at Mar. 31, 2023 $ 6 496,523 (251) (167,438) $ 328,840
Balance, Beginning (in shares) at Mar. 31, 2023 63,274,732        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options and vesting of restricted stock   31     31
Exercise of stock options and vesting of restricted stock (shares) 135,326        
Purchase of common stock under employee stock purchase plan   338     338
Purchase of common stock under employee stock purchase plan (in shares) 48,874        
Stock-based compensation   4,011     4,011
Other comprehensive loss     (296)   (296)
Net loss       (21,469) (21,469)
Balance, Ending at Jun. 30, 2023 $ 6 $ 500,903 $ (547) $ (188,907) $ 311,455
Balance, Ending (in shares) at Jun. 30, 2023 63,458,932       63,458,932